AbbVie | ABBV - Nettoeinkommen





Nettoeinkommen Veränderung Datum
AbbVie USD 4.22B 605M 2026-09
Abbott USD 920M 8M 2026-09
ALKERMES USD 501K 66.98M 2026-06
Amgen USD 2.38B 556M 2026-06
AstraZeneca USD 3.12B 610M 2026-09
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD -122.83M 167.59M 2026-09
Bristol-Myers Squibb USD 2.16B 1.16B 2026-09
Coherus Biosciences USD -37.64M 2.11M 2025-12
Eisai JPY 18.24B 21.49B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
J&J USD 210M 5.32B 2026-09
Medtronic USD 1.47B 227M 2026-06
Merck USD 5.07B 6.4B 2026-09
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novartis USD 1.2B 2.06B 2026-09
Pacira USD 4.65M 1.74M 2026-06
Perrigo USD 74.5M 473.1M 2026-06
Pfizer USD 3.24B 3.49B 2026-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 3.02B 2.68B 2026-09
UCB EUR 1.08B 608M 2025-12
Ultragenyx Pharmaceutical USD -92M 93M 2026-06
United Therapeutics USD 333M 58.1M 2026-06
Vertex Pharmaceuticals USD 653.6M 446.2M 2026-09
Zoetis USD 691M 90M 2026-06